Here are three important facts:
1. Endoscopy profits were $442 million, up from $400 million over the same period in in 2017.
2. Second quarter sales were $2.490 billion, an increase of 10.3 percent on a reported basis , 8.6 percent on an operational basis and 7.9 percent on an organic basis, compared to the prior year.
3. The company reported GAAP earnings of $555 million or $0.40 per share, compared to GAAP earnings of $146 million or $0.11 last year, and achieved adjusted earnings per share of $0.41, compared to $0.32 last year.
More articles on GI and endoscopy:
GI leader to know: Dr. Justin Howard of University of Minnesota Medical Center
Exact Sciences, Lumendi & more — 4 GI company key notes
10 most-read GI stories in 2018
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.